ArticleComputational and structural biotechnology journal2025
Structural elucidation of four fungal hydrophobins belonging to classes I and II: Results from Alphafold and accelerated molecular dynamics simulations.
Article in Computational and structural biotechnology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Mechanistic Insights into Effector-Mediated Modulation of Rice Mitochondrial Proteins by Magnaporthe oryzae.Molecular biotechnology · 2026Article
- Transcriptomic insights into common defense mechanisms ofFrontiers in fungal biology · 2026Article
- AlphaFold in protein structure and function prediction.Computational and structural biotechnology journal · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hydrophobins (HFB) find application in various industries including biotechnology and medical devices; therefore, it is imperative to elucidate and learn more about their folded structures. Few fungal HFB protein structures are available in the Protein Data Bank (PDB), and fewer have been elucidated using homology modeling or short molecular dynamics (MD) simulations in the literature. Moreover, many homology modeling algorithms will only model the region with sequence identity. Therefore, we turned towards the state-of-the-art, artificial intelligence powered AlphaFold. It performed well in predicting the core β-barrel, a characteristic of HFBs, except for HFB9A which was unfolded with low confidence scores. These initial structures were then prepared for accelerated MD simulation in the hope of observing higher protein folding. With 500 ns long aMD simulations, we were able to obtain folded and energetically stable conformations for all the proteins except HFB9A, which exhibited much higher disorder, connected with higher atomic fluctuation, lowest hydrophobicity and overall compactness, and lesser secondary structure formation as visualized during the aMD simulation. The underlying intrinsic disorder in the HFBs was found to be the basis of harder-to-reach folding by AF2 which can be compensated by enhanced sampling MD simulations like the aMD technique. The characteristic two disordered loops of class I HFBs were obtained for SC3, while HFB9A showed that not all class I HFBs contain them. Class II HFBs were more stable, folded and compact with secondary structure motifs conserved throughout the trajectory which can be correlated with their comparatively much lower intrinsic disorder.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.